Protein kinase CK2 is important for the function of glioblastoma brain tumor initiating cells
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protein kinase CK2 is important for the function of glioblastoma brain tumor initiating cells
Authors
Keywords
Glioblastoma, CK2, BTIC, CD133, EGFR
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 132, Issue 2, Pages 219-229
Publisher
Springer Nature
Online
2017-02-08
DOI
10.1007/s11060-017-2378-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
- (2016) Michele Ceccarelli et al. CELL
- PERK-Dependent Activation of JAK1 and STAT3 Contributes to Endoplasmic Reticulum Stress-Induced Inflammation
- (2014) G. P. Meares et al. MOLECULAR AND CELLULAR BIOLOGY
- Casein kinase 2α regulates glioblastoma brain tumor-initiating cell growth through the β-catenin pathway
- (2014) R T Nitta et al. ONCOGENE
- Autophagosome-Mediated EGFR Down-Regulation Induced by the CK2 Inhibitor Enhances the Efficacy of EGFR-TKI on EGFR-Mutant Lung Cancer Cells with Resistance by T790M
- (2014) Kwang Sup So et al. PLoS One
- Targeting Protein Kinase CK2 Suppresses Prosurvival Signaling Pathways and Growth of Glioblastoma
- (2013) Y. Zheng et al. CLINICAL CANCER RESEARCH
- Glioblastoma and Other Malignant Gliomas
- (2013) Antonio Omuro JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake
- (2013) William A Flavahan et al. NATURE NEUROSCIENCE
- Molecular interactions of ErbB1 (EGFR) and integrin- 1 in astrocytoma frozen sections predict clinical outcome and correlate with Akt-mediated in vitro radioresistance
- (2013) M. Petras et al. NEURO-ONCOLOGY
- CD133 Is Essential for Glioblastoma Stem Cell Maintenance
- (2013) Paola Brescia et al. STEM CELLS
- Combined inhibition of EGFR and CK2 augments the attenuation of PI3K-Akt-mTOR signaling and the killing of cancer cells
- (2012) Joshua Bliesath et al. CANCER LETTERS
- Single-Cell Expression Analyses during Cellular Reprogramming Reveal an Early Stochastic and a Late Hierarchic Phase
- (2012) Yosef Buganim et al. CELL
- Inhibition of CK2α Down-Regulates Hedgehog/Gli Signaling Leading to a Reduction of a Stem-Like Side Population in Human Lung Cancer Cells
- (2012) Shulin Zhang et al. PLoS One
- Inhibition of Casein kinase-2 induces p53-dependent cell cycle arrest and sensitizes glioblastoma cells to tumor necrosis factor (TNFα)-induced apoptosis through SIRT1 inhibition
- (2012) D Dixit et al. Cell Death & Disease
- Therapeutic Potential of AZD1480 for the Treatment of Human Glioblastoma
- (2011) B. C. McFarland et al. MOLECULAR CANCER THERAPEUTICS
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy
- (2010) A. Siddiqui-Jain et al. CANCER RESEARCH
- Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients
- (2008) F. Zeppernick et al. CLINICAL CANCER RESEARCH
- Malignant Gliomas in Adults
- (2008) Patrick Y. Wen et al. NEW ENGLAND JOURNAL OF MEDICINE
- SOX2Silencing in Glioblastoma Tumor-Initiating Cells Causes Stop of Proliferation and Loss of Tumorigenicity
- (2008) Rosaria Maria Rita Gangemi et al. STEM CELLS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now